In this issue:
Prophylactic donidalorsen efficacious for HAE
First-in-class agent garadacimab prevents HAE attacks
COVID-19 vaccines provide durable real-world protection against death
Vaccination with H2 HA influenza protein elicits broad cross-reactive B cell response
Maternal antibodies may protect against congenital CMV infection
PCV13 vaccine for older adults reduces pneumonia hospitalisations
Gardasil™ HPV vaccine offers long-term protection against genital warts and cancer
Omalizumab significantly improves CRSwNP but doesn’t induce durable remission
COVID vaccines are less immunogenetic in patients with antibody deficiency
Mepolizumab provides a sustained benefit in severe eosinophilic asthma
Please login below to download this issue (PDF)